You’re almost there!
It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.
Customer Service Team
Confidentiality & Authenticity Assured
- Fully Regulated UK Pharmacy
- Authentic UK sourced medicines only.
- Trading for more than 10 years.
- Information Governance lead ensures all data is confidential
Need Help With Your Questionnaire?
Our customer service team is on hand Monday-Friday to help you with your queries.
UK licenced medication
Cancel any time
100% Discretion & Confidentiality
About Evra Patches
Buy Evra Patches online. Fully regulated UK pharmacy.
Evra Patches are contraceptive patches intended for woman of fertility age. Evra patches contain a combination of hormones norelgestromin and ethinyl estradiol. They are used to prevent pregnancy.
Only one transdermal patch is to be worn at a time.
Each used transdermal patch is removed and immediately replaced with a new one on the same day of the week (Change Day) on Day 8 and Day 15 of the cycle. Transdermal patch changes may occur at any time on the scheduled Change Day. The fourth week is transdermal patch-free starting on Day 22.
A new contraceptive cycle begins on the next day following transdermal patch-free week; the next EVRA transdermal patch should be applied even if there has been no withdrawal bleeding or if withdrawal bleeding has not yet stopped.
Under no circumstances should there be more than a 7-day transdermal patch-free interval between dosing cycles. If there are more than 7 transdermal patch-free days, the user may not be protected against pregnancy. A non-hormonal contraceptive must then be used concurrently for 7 days. The risk of ovulation increases with each day beyond the recommended contraceptive-free period. If intercourse has occurred during such an extended transdermal patch-free interval, the possibility of pregnancy should be considered.
EVRA should be applied to clean, dry, hairless, intact healthy skin on the buttock, abdomen, upper outer arm or upper torso, in a place where it will not be rubbed by tight clothing. EVRA should not be placed on the breasts or on skin that is red, irritated or cut. Each consecutive transdermal patch should be applied to a different place on the skin to help avoid potential irritation, although they may be kept within the same anatomic site.
The transdermal patch should be pressed down firmly until the edges stick well.
To prevent interference with the adhesive properties of the transdermal patch, no make-up, creams, lotions, powders or other topical products should be applied to the skin area where the transdermal patch is placed or where it will be applied shortly.
It is recommended that users visually check their transdermal patch daily to ensure continued proper adhesion.
The EVRA transdermal patch should not be cut, damaged or altered in any way as this may compromise contraceptive effectiveness.
Used transdermal patches should be discarded carefully in accordance with the instructions given in section 6.6.